ATLAS fair value
ATLAS has no fair value for this stock today.
Laurus Labs share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
Prices as of Oct 26, 2026 · INR
ATLAS has no fair value for this stock today.
51%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Laurus Labs a 51% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,967 and ₹2,166; in 9 out of 10, between ₹1,806 and ₹2,360. Estimated annual volatility is 27%.
ATLAS does not publish a fair value for LAURUSLABS.NSE right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks LAURUSLABS.NSE has traded between ₹917.95 and ₹2,089. Today it is 1.4% below that high and 124% above its low.
On the business: net margin is 15.0%; it trades at 97.4 times earnings.
Its beta is 0.34: it tends to move less than the market.
Laurus Labs Ltd. is a prominent pharmaceutical company engaged in the manufacturing and commercialization of high-quality generic Active Pharmaceutical Ingredients (APIs), formulations, and specialty ingredients.
Want to see everything about Laurus Labs?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Laurus Labs Ltd. is a prominent pharmaceutical company engaged in the manufacturing and commercialization of high-quality generic Active Pharmaceutical Ingredients (APIs), formulations, and specialty ingredients.
51%: close to a coin flip. In half of the simulated outcomes, LAURUSLABS.NSE ends the month between ₹1,967 and ₹2,166.
Laurus Labs's market capitalization is ₹1.1T. Its price-to-earnings (P/E) ratio is 97.4: you pay ₹97.4 for each ₹1.00 of yearly earnings.
Yes. LAURUSLABS.NSE's current dividend yield is 0.12% at today's price (₹2,059).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy